CN Patent

CN104066706B — 炎症的治疗

Assigned to Notable Labs Ltd · Expires 2017-12-19 · 8y expired

What this patent protects

本文公开了治疗炎性疾病或病症的方法，以及用于治疗炎性疾病或病症的药物组合物和试剂盒。所述方法、组合物和试剂盒利用至少一种药剂，所述至少一种药剂能够显示至少两种选自下述的活性：a)抑制CD14活性和/或与CD14活性有关的信号通路；b)抑制TLR2活性和/或与TLR2活性有关的信号通路；和c)抑制单核细胞趋化性。

USPTO Abstract

本文公开了治疗炎性疾病或病症的方法，以及用于治疗炎性疾病或病症的药物组合物和试剂盒。所述方法、组合物和试剂盒利用至少一种药剂，所述至少一种药剂能够显示至少两种选自下述的活性：a)抑制CD14活性和/或与CD14活性有关的信号通路；b)抑制TLR2活性和/或与TLR2活性有关的信号通路；和c)抑制单核细胞趋化性。

Drugs covered by this patent

Patent Metadata

Patent number
CN104066706B
Jurisdiction
CN
Classification
—
Expires
2017-12-19
Drug substance claim
No
Drug product claim
No
Assignee
Notable Labs Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.